From Wikipedia, the free encyclopedia
Acquisition history
[edit]
The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list):
Takeda Pharmaceutical Company
|
|
|
|
|
|
|
|
|
|
Takeda Pharmaceuticals (Est 1781)
|
|
|
Syrrx (Acq 2005)
|
|
|
|
Millennium Pharmaceuticals (Acq 2008)
|
|
COR Therapeutics (Acq 2002)
|
|
|
Cambridge Discovery Chemistry (Acq 2000)
|
|
|
Leukosite (Acq 1999)
|
|
|
|
|
|
Nycomed (Acq 2011)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shire Plc (Acq 2018)
|
|
Baxalta (Acq 2016)
|
|
|
|
Dyax (Acq 2015)
|
|
|
|
Foresight Biotherapeutics (Acq 2015)
|
|
|
|
Meritage Pharma (Acq 2015)
|
|
|
|
NPS Pharmaceuticals (Acq 2015)
|
|
|
|
Lumena (Acq 2014)
|
|
|
|
Fibrotech (Acq 2014)
|
|
|
ViroPharma (Acq 2013)
|
Lev Pharmaceuticals (Acq 2008)
|
|
|
|
SARcode Bioscience Inc (Acq 2013)
|
|
|
|
Premacure AB (Acq 2013)
|
|
|
|
Lotus Tissue Repair, Inc (Acq 2013)
|
|
|
|
FerroKin BioSciences (Acq 2012)
|
|
|
|
Advanced BioHealing (Acq 2011)
|
|
|
|
Movetis (Acq 2012)
|
|
|
|
Jerini (Acq 2008)
|
|
|
|
New River Pharmaceuticals Inc (Acq 2007)
|
|
|
|
Transkaryotic Therapeutics (Acq 2005)
|
|
|
|
Biochem Canada (Acq 2001)
|
|
|
|
Richwood Pharmaceutical Company (Acq 1997)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|